These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8142253)

  • 1. Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
    Horsman MR; Chaplin DJ
    Br J Cancer; 1994 Apr; 69(4):648-54. PubMed ID: 8142253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferase.
    Horsman MR; Brown DM; Hirst DG; Brown JM
    Br J Cancer; 1986 Feb; 53(2):247-54. PubMed ID: 3006735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
    Brown JM; Hirst DG
    Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P; Workman P
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
    Martin WM; McNally NJ; De Ronde J
    Br J Cancer; 1981 Jun; 43(6):756-66. PubMed ID: 7248157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy.
    Horsman MR; Høyer M; Honess DJ; Dennis IF; Overgaard J
    Radiother Oncol; 1993 May; 27(2):131-9. PubMed ID: 8356223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions.
    Tannock I; Guttman P
    Br J Cancer; 1981 Feb; 43(2):245-8. PubMed ID: 7470389
    [No Abstract]   [Full Text] [Related]  

  • 8. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.
    Teicher BA; Lazo JS; Sartorelli AC
    Cancer Res; 1981 Jan; 41(1):73-81. PubMed ID: 7448778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP; Hirst DG; Brown JM
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mouse tumor model system (RIF-1) for comparison of end-point studies.
    Twentyman PR; Brown JM; Gray JW; Franko AJ; Scoles MA; Kallman RF
    J Natl Cancer Inst; 1980 Mar; 64(3):595-604. PubMed ID: 6928244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization in vivo: a study with an homologous series of 2-nitroimidazoles.
    Chaplin DJ; Sheldon PW; Stratford IJ; Ahmed I; Adams GE
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Oct; 44(4):387-98. PubMed ID: 6605324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR; Evans JW; Brown JM
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.